Scaling up innovation in healthcare - A Methodology Framework 2015Marc Lange
This presentation introduce a methodology scaling-up developed by "doers and shapers" internationally known for their expertise in eHealth and digital health
Evaluating Health Technology Assessment Reports and New Assessment Techniques...bpstat
2nd Annual Health Outcomes and Pharmacoeconomics Research Conference
• Setting up internal processes to ensure proper Health
Technology Assessment (HTA)
• Exploring initiatives to translate reported outcomes to
ensure proper understanding of data
• Assessing the key HTA entities in the U.S. and establishing
assessment protocol
• Differentiating HTA strategies with new technology
assessment strategies to improve assessment processes
The MaRS EXCITE (Excellence in Clinical Innovation and Technology Evaluation) program helps innovators collaborate with the health system to accelerate the pace of adoption of innovative health technologies in Ontario and global markets.
At the end of the program, innovators will have feedback and data on the effectiveness, competitiveness, and economic value of their medical devices or health technology. With this data, innovators are better equipped to approach payers in multiple markets for reimbursement.
Prioritized by senior executives from the health system, only technologies that have true breakthrough potential are allowed into the program.
For more information visit www.marsdd.com.
Presentation delivered by Dr Adham Ismail, Regional Adviser, Health Technologies at the 62nd Session of the WHO Regional Committee for the Eastern Mediterranean
Scaling up innovation in healthcare - A Methodology Framework 2015Marc Lange
This presentation introduce a methodology scaling-up developed by "doers and shapers" internationally known for their expertise in eHealth and digital health
Evaluating Health Technology Assessment Reports and New Assessment Techniques...bpstat
2nd Annual Health Outcomes and Pharmacoeconomics Research Conference
• Setting up internal processes to ensure proper Health
Technology Assessment (HTA)
• Exploring initiatives to translate reported outcomes to
ensure proper understanding of data
• Assessing the key HTA entities in the U.S. and establishing
assessment protocol
• Differentiating HTA strategies with new technology
assessment strategies to improve assessment processes
The MaRS EXCITE (Excellence in Clinical Innovation and Technology Evaluation) program helps innovators collaborate with the health system to accelerate the pace of adoption of innovative health technologies in Ontario and global markets.
At the end of the program, innovators will have feedback and data on the effectiveness, competitiveness, and economic value of their medical devices or health technology. With this data, innovators are better equipped to approach payers in multiple markets for reimbursement.
Prioritized by senior executives from the health system, only technologies that have true breakthrough potential are allowed into the program.
For more information visit www.marsdd.com.
Presentation delivered by Dr Adham Ismail, Regional Adviser, Health Technologies at the 62nd Session of the WHO Regional Committee for the Eastern Mediterranean
Chris Cleary, Vice President of Corporate Development, Medtronic presented at MEDTECH 2014 on Fulfilling the Mission: Medtronic Embraces Change to Respond to an Evolving Healthcare Landscape.
Panaxea offers a wide range of services related to healthcare and Innovations. Placing more influence and stress on three basic services: Health Technology Assessment, Health Services and System Research and Health Innovation Assessment Consultancy.
2B Kalfhaus Opportunities and Challenges of Telemedicine EHiN 2014IKT-Norge
Lars Kalfhaus
Country Manager Roche Diabetes Care (ES)
Connect, Engage and Take Decisions
Opportunities and Challenges of Telemedicine Implementation
EHiN 2014, IKT-Norge og HOD
Building Consumer-Facing Health Devices and Apps and Doing it RightKent State University
For the HIMSS Delaware Valley Chapter. solve a problem; prototype, pilot, adopt and scale. FDA regulations, evidence, health behavior change, data integration
In introduction to SILS 2015 panel of international specialists on “Aging of the Population: Opportunity or Threat?”
By : Carine Boonen, Flanders' Care (Belgium)
At Sherbrooke International Life Sciences Summit - 2nd edition | September 28/29/30 2015
www.sils-sherbrooke.com
15 years of e health in canada observations on the challenge of balancing inn...PwC Sverige
Till årets Vitalis-konferens i Göteborg den 22-24 april, som är den största mötesplatsen för eHälsa i norden, bjöd vi in Will Falk, PwC Kanadas Managing Partner inom Health Industries. Will höll ett seminarium tillsammans med Torsten Håkansta, generaldirektör på eHälsomyndigheten. Han presenterade Kanadas erfarenhet av eHälsa med början 2001 då InfoWay grundades av den Kanadensiska staten för att påskynda utvecklingen och användandet av effektiva digitala lösningar i hela landet. Fokus lades på vad som bidragit till InfoWays framgång och de drastiska förändringar som skett på marknaden sedan InfoWay grundades för mer än 10 år sedan. Slutligen identifierade Will sex områden som organisationer liknande InfoWay bör ha i beaktande framåt, bland annat vilken påverkan som konsumentprodukter och nya aktörer kommer att ha på marknaden.
This is a Dean's Case Competition project in Som-Binghamton University. I did it with my team in Spring 2014 to present our the overall situation of Medtronic Inc.
Chris Cleary, Vice President of Corporate Development, Medtronic presented at MEDTECH 2014 on Fulfilling the Mission: Medtronic Embraces Change to Respond to an Evolving Healthcare Landscape.
Panaxea offers a wide range of services related to healthcare and Innovations. Placing more influence and stress on three basic services: Health Technology Assessment, Health Services and System Research and Health Innovation Assessment Consultancy.
2B Kalfhaus Opportunities and Challenges of Telemedicine EHiN 2014IKT-Norge
Lars Kalfhaus
Country Manager Roche Diabetes Care (ES)
Connect, Engage and Take Decisions
Opportunities and Challenges of Telemedicine Implementation
EHiN 2014, IKT-Norge og HOD
Building Consumer-Facing Health Devices and Apps and Doing it RightKent State University
For the HIMSS Delaware Valley Chapter. solve a problem; prototype, pilot, adopt and scale. FDA regulations, evidence, health behavior change, data integration
In introduction to SILS 2015 panel of international specialists on “Aging of the Population: Opportunity or Threat?”
By : Carine Boonen, Flanders' Care (Belgium)
At Sherbrooke International Life Sciences Summit - 2nd edition | September 28/29/30 2015
www.sils-sherbrooke.com
15 years of e health in canada observations on the challenge of balancing inn...PwC Sverige
Till årets Vitalis-konferens i Göteborg den 22-24 april, som är den största mötesplatsen för eHälsa i norden, bjöd vi in Will Falk, PwC Kanadas Managing Partner inom Health Industries. Will höll ett seminarium tillsammans med Torsten Håkansta, generaldirektör på eHälsomyndigheten. Han presenterade Kanadas erfarenhet av eHälsa med början 2001 då InfoWay grundades av den Kanadensiska staten för att påskynda utvecklingen och användandet av effektiva digitala lösningar i hela landet. Fokus lades på vad som bidragit till InfoWays framgång och de drastiska förändringar som skett på marknaden sedan InfoWay grundades för mer än 10 år sedan. Slutligen identifierade Will sex områden som organisationer liknande InfoWay bör ha i beaktande framåt, bland annat vilken påverkan som konsumentprodukter och nya aktörer kommer att ha på marknaden.
This is a Dean's Case Competition project in Som-Binghamton University. I did it with my team in Spring 2014 to present our the overall situation of Medtronic Inc.
Homeland Tour June 2008 --------
The Wilsons Discover Sweden June 16-22, 2009
Exploring Sweden Wilson’s homeland.
Tour areas from which the Wilsons originated in Sweden: Gothenburg, Uddevalla and the Parishes of Dragsmark, Bokenas. We met wonderful relatives (3rd & 4th cousins) shared the Mid Summer’s celebrations and fun meals with singing, visited museums, cemeteries & other relevant sites which were prominent in the Wilson ancestral lives.
What role does technology play in the job search for 2015? How does a job seeker emphasize the positives in technology and de-emphasize the negatives? What role do keywords play? Can social media help? All this and more...
The Homeland Tour June 2009
The Wilsons Discover Sweden
THe Wilson extended family members toured areas from which we originated in Sweden: Gothenburg, Uddevalla and the Parishes of Dragsmark, Bokenas. We met wonderful third cousins +, enjoyed meals and celebrations with them for Mid Summer\'s eve, visited museums, cemeteries & other relevant sites which were prominent in the Wilson ancestral lives.
The tour will be remembered by all for our lives!
How to manage trade show leads and link them to CRMDoug Noftall
Discover this great tool to help you link your trade show leads to most CRM's. By allowing customers to view videos, PowerPoint presentations and PDF's directly in your booth, they can send your digitally formated content directly to them in just a few clicks. This tools has an easy CRM integration so sale staff can easily and quickly follow-up on leads while giving you extensive back-end reporting options.
Other benefits are:
- Go green and eliminate the use of paper
- Significant reduction of shipping, storage and disposal costs of printed material–all data is in one safe location
- Accessible on any computing device from smartphones to laptops
- Gives booth sales & marketing representatives the opportunity to qualify the attendee
Personal Connected Health Alliance StrategyPCHA2016
Discover the new 5 year strategy of the Personal Connected Health Alliance (PCHA) to achieve personal health and wellness for everyone. Visit pchalliance.org for more information about PCHA.
Join us at the Connected Health Conference in Washington D.C. on December 11-14, 2016. For more information, visit www.pchaconference.org.
Personal connected health is currently characterized by limited thought leadership, insufficient coordination and collaboration, and a lack of awareness and understanding of the full potential by all stakeholders: public, providers, policymakers, industry and patients. The Personal Connected Health Alliance is defining the the field of personal connected health to inspire market and policy innovation, research and collective action for sustained adoption of personal connected health technology. The vision is better health and well being for all through increased personal responsibilities and connectivity as well as improved care delivery enabled by technology.
Personal Connected Health Alliance StrategyMary Sheridan
Discover the new 5 year strategy of the Personal Connected Health Alliance (PCHA) to achieve personal health and wellness for everyone. Visit pchalliance.org for more information about PCHA.
Join us at the Connected Health Conference in Washington D.C. on December 11-14, 2016. For more information, visit www.pchaconference.org.
The 2023 Digital Health Barometer_compressed.pdfJordiCarreras13
Data interoperability requires the adoption and
implementation of common and (ideally) open
standards. Lack of interoperability limits the
re-use of data between healthcare organisations
within a country and across borders. The rise of
cloud platforms and mobile technology further
complicates the data environment. “Data gets
captured and it is quite complex and hard to
share,” says David Hansen, CEO of the Australian
e-Health Research Centre, CSIRO. “When shared,
it is often not computable. Human intervention
is needed to do analytics and this is really
expensive.”
All countries except Spain achieve the highest
score on this indicator, demonstrating that
digital health and health information industrybased
technical standards for data exchange,
transmission, messaging, security, privacy and
hardware are in use in the majority of applications
and systems to ensure the availability of highquality
data.
Digital health literacy and internet connectivity
are ‘super’ social determinants of health, as
they have the power to affect the wider social
determinants of health.17 Although the use of
digital tools – such as apps, patient portals, and
monitoring devices – provides better support
beyond clinical settings, greater reliance on them
can increase the disparity between people with
digital access and skills and those without, and (by
extension) health disparities.18 “One of the major
concerns globally in digital health has been tech
equity,” says Majmudar. “The digital divide could
worsen. You need access to the internet, tools
and resources. Every country should focus on
connectivity, including the US. Can people afford
the data plans they need to access telemedicine
and remote care? Do we have connectivity in
every area, urban or rural?”
Information+Integration ? Innovation an HL7/EFMI/HIMSS @eHealthweek2015 in Rigachronaki
Join us to explore “Interoperability in action: information + integration = innovation?” and engage in lively debate on how rethinking interoperability standards and continuing education can bridge divides, change cultures, and open markets!
Perspectives from health management, industry, government, health education, and standardization exemplify challenges and opportunities for liberation of data that can drive desired social and technological innovation.
This is a call for action to explore how the partnership of HL7, EFMI and HIMSS can catalyze the equation “information + integration = innovation” to bridge divides, change culture and open markets.
Tripartite dimension of interaction of patients, regulators and industry (Jan...jangeissler
Tripartite dimension of interaction of patients, regulators and industry, presented by Jan Geissler as a scene-setting presentation at the EUPATI Workshop on the interaction of patients, regulators and industry on 20 July 2016 in Berlin
MAPS2018 Keynote address on EY report: Life Sciences 4.0 – Securing value thr...EY
Summary: This keynote address presented by Pamela Spence, EY Global Life Sciences Leader (pspence2@uk.ey.com) at MAPS 2018 – the annual meeting for Medical Affairs Professional Society – discusses our latest life sciences report and the industry demands for a customer-focused, data driven approach to health care. We describe the accelerating pace of change as technological advances and the escalating expectations of payers, physicians and patient consumers are combining to disrupt the life sciences business model. Data and algorithms that maximize health outcomes based on individual needs and preferences are becoming the ultimate health care consumable. To create value now and in a future that we call Life Sciences 4.0, life sciences companies must build – or participate in – interoperable information systems that collect, combine and share data. For more on our report, Progressions 2018 – Life Sciences 4.0, please go to www.ey.com/progressions
Professor George Crooks - ECO 19: Care closer to homeInnovation Agency
Presentation by Professor George Crooks, Chief Executive Officer, The Digital Health and Care Innovation Centre at ECO 19: Care closer to home on Tuesday 9 July at Deepdale Stadium.
Software Delivery At the Speed of AI: Inflectra Invests In AI-Powered QualityInflectra
In this insightful webinar, Inflectra explores how artificial intelligence (AI) is transforming software development and testing. Discover how AI-powered tools are revolutionizing every stage of the software development lifecycle (SDLC), from design and prototyping to testing, deployment, and monitoring.
Learn about:
• The Future of Testing: How AI is shifting testing towards verification, analysis, and higher-level skills, while reducing repetitive tasks.
• Test Automation: How AI-powered test case generation, optimization, and self-healing tests are making testing more efficient and effective.
• Visual Testing: Explore the emerging capabilities of AI in visual testing and how it's set to revolutionize UI verification.
• Inflectra's AI Solutions: See demonstrations of Inflectra's cutting-edge AI tools like the ChatGPT plugin and Azure Open AI platform, designed to streamline your testing process.
Whether you're a developer, tester, or QA professional, this webinar will give you valuable insights into how AI is shaping the future of software delivery.
Accelerate your Kubernetes clusters with Varnish CachingThijs Feryn
A presentation about the usage and availability of Varnish on Kubernetes. This talk explores the capabilities of Varnish caching and shows how to use the Varnish Helm chart to deploy it to Kubernetes.
This presentation was delivered at K8SUG Singapore. See https://feryn.eu/presentations/accelerate-your-kubernetes-clusters-with-varnish-caching-k8sug-singapore-28-2024 for more details.
Smart TV Buyer Insights Survey 2024 by 91mobiles.pdf91mobiles
91mobiles recently conducted a Smart TV Buyer Insights Survey in which we asked over 3,000 respondents about the TV they own, aspects they look at on a new TV, and their TV buying preferences.
UiPath Test Automation using UiPath Test Suite series, part 3DianaGray10
Welcome to UiPath Test Automation using UiPath Test Suite series part 3. In this session, we will cover desktop automation along with UI automation.
Topics covered:
UI automation Introduction,
UI automation Sample
Desktop automation flow
Pradeep Chinnala, Senior Consultant Automation Developer @WonderBotz and UiPath MVP
Deepak Rai, Automation Practice Lead, Boundaryless Group and UiPath MVP
Epistemic Interaction - tuning interfaces to provide information for AI supportAlan Dix
Paper presented at SYNERGY workshop at AVI 2024, Genoa, Italy. 3rd June 2024
https://alandix.com/academic/papers/synergy2024-epistemic/
As machine learning integrates deeper into human-computer interactions, the concept of epistemic interaction emerges, aiming to refine these interactions to enhance system adaptability. This approach encourages minor, intentional adjustments in user behaviour to enrich the data available for system learning. This paper introduces epistemic interaction within the context of human-system communication, illustrating how deliberate interaction design can improve system understanding and adaptation. Through concrete examples, we demonstrate the potential of epistemic interaction to significantly advance human-computer interaction by leveraging intuitive human communication strategies to inform system design and functionality, offering a novel pathway for enriching user-system engagements.
Generating a custom Ruby SDK for your web service or Rails API using Smithyg2nightmarescribd
Have you ever wanted a Ruby client API to communicate with your web service? Smithy is a protocol-agnostic language for defining services and SDKs. Smithy Ruby is an implementation of Smithy that generates a Ruby SDK using a Smithy model. In this talk, we will explore Smithy and Smithy Ruby to learn how to generate custom feature-rich SDKs that can communicate with any web service, such as a Rails JSON API.
From Siloed Products to Connected Ecosystem: Building a Sustainable and Scala...
pHealth EU-USA Workshop
1. Intelligent, Manageable and Adaptive
pHealth Platform. Are We There?
Dr. Vicente Traver
Includes some contributions of Session 6: A global market: analysis and future
trends from pHealth 08, that took place in Valencia (May 08)
Valencia, Spain
2008, April 20th 1
http://www.phealth2008.com
2. 2
Intelligent, manageable and adaptive pHealth
platform. Where are we?
R&D Industry Market
Tech
Transference
Innovation
3. 3
Chronic Disease Management and Shared Care
case
management
disease/care
management
self care
support/
management
level 3
high complexity
level 2
high risk
level 1
70-80% of
CDM
population
5. Needs for a pHealth market
5
Demographic and lifestyle factors
Consumerism trends
Chronic conditions
Healthy lifestyle is “in”
New paradigm for health promotion and care
delivery
Increase in citizen awareness
Technology is not the limiting
factor. There are powerful
technologies existing and still
evolving
6. Barriers for pHealth market
6
Technology Barriers — Interfacing with existing legacy systems
Regulatory/Policy Barriers — Lack of data standards; data security
Market Barriers — Fragmentation of end-user market
Financial Barriers — Shrinking operating margins in healthcare
Cultural Barriers — Physicians slow to adopt new technology
Organizational Barriers — Protect the status quo
7. Open questions within the pHealth
market
7
Professional stakeholders:
• What is the medical impact? Who will benefit or lose by
changing to using personal healthcare systems (PHS)?
• Who will pay for pHealth?
Patients/customers:
• What does it bring to me? Is this really necessary /
helpful?
8. Open questions within the pHealth
market
8
pHealth services provider
• How to keep a solid business model independently from
the place where the solution is to be implemented?
(Differences in health system of the EU member states
make holistic solution approaches a problem )
• How to integrate pHealth into existing or new healthcare
delivery models?
9. Where to find answers …
9
by clinical,
social,
technological
and economical
validation
by co-operation
on international
level bringing
together all
involved
stakeholders
by
standardization
efforts
by creation of a
law and ethics
framework
10. Answers by …. validation
10
Clinical and economic validation of pHealth technologies and
services for reimbursement is a must
Acceptance by medical stakeholders requires statistical evidence
Economic studies on cost / benefit analysis are required
pHealth solutions for consumers need medical endorsement and
therefore also medical proof
11. Answers by …. cooperation in
international projects
11
Bridging the gap between research and the market
Patient studies force the project to achieve a certain maturity level of hard- and
software (CE marking, usability pre-studies, etc.)
Mature solutions lower threshold for exploitation of project results
lnteroperability, user-friendliness, reliability and dependability need to be properly
addressed before pHealth receive support and commitment from all stakeholders
Support to develop regulatory, legal and reimbursement infrastructure to support
new models of healthcare delivery via pHealth
12. 12
MyHeart
IST-2002-507816
Aim: Fighting cardiovascular diseases
by prevention and early diagnosis
Technologies: Smart clothes, sensors,
on-body electronics, software,
user devices, professional platform
EU IST e-health (6th framework)
• Start: 31.12.2003
• Duration: 60 months
• Partners: 30 (10 countries)
• Total manpower: 75
• Total budget: ~33 M€
• EC-funding: ~16 M€
13. 13
FP7 Project
• Start: 1. March 2008
• Duration: 4 years
• Partners: 18 (9 countries)
• Announced EC-funding: ~14.1 M€
– Largest FP7 project in “ICT for Health”
• Coordinator: Philips
Patient Compliance is a major problem in healthcare today.
• Aim: Closed-loop management of medication and lifestyle compliance
• Applications: Heart Failure & Coronary Heart Disease
• Solution:
– Multi-parametric monitoring of vital signs and other variables
– Physiological and statistical modelling of medication and lifestyle effects
– Motivating patients to adhere to treatment regime
– Decision support system for physicians and patients
Patient study in last project year will
assess improvement in patient health
outcome and compliance against control
group.
FP7 – 216695
14. Answers by …. standardization
14
• Non-profit, open industry alliance of the finest
healthcare and technology companies in the world
joining together in collaboration to improve the quality
of personal healthcare
150 Member Companies (founders: Centre for Connected Health, Cisco, Intel, Kaiser Permanente,
Medtronic, Panasonic, Philips, Samsung, Sharp, Welch Allyn)
– personal telehealth eco-system
– system of interoperable personal telehealth solutions that empower
people and organizations to better manage health and wellness
• Other organisations, forums and standards: eHSCG, x73
15. Answers by …. law and ethics framework
15
• … the weakest point
• Work is being done
• Continua – work with regulatory agencies
• WHO resolution on eHealth - 58th World Health
Assembly in Geneva, on May 23, 2005
• Several ethic codes
• HON
16. To discuss and conclude
16
pHealth will happen – there is no other way. The question is the
date.
R&D projects, standardization activities, and law & ethics work are
still needed to provide medical evidence and assure 100%
interoperability in a common stablished framework.
More technology implies more investments, and so will be driven by
clinical and care need with professional involvement and analysis of
reimbursement schemes.
Do not forget e-health 2.0 and the ‘citizens’ with contributions from
individuals with similar interests (‘self guided’)
The solution relies on the services (access to personal data
whenever and wherever, disease management programs,
continuous health monitoring, risk assessment services,…), not in
the tones of information.
17. Universidad Politécnica de Valencia
Instituto ITACA – Edif. 8G
Camino de Vera, s/n 46022 Valencia Spain
Tel: +34 963 877 606
Thanks for your attention
Vicente Traver
vtraver@itaca.upv.es
